Reviva Pharmaceuticals Holdings, Inc.
General ticker "RVPH" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $55.8M
Reviva Pharmaceuticals Holdings, Inc. does not follow the US Stock Market performance with the rate: -41.2%.
Estimated limits based on current volatility of 11.3%: low 1.24$, high 1.55$
Short-term RVPH quotes
Long-term RVPH plot
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $2.43MM | $10.10MM | $24.31MM |
| Operating Income | $-2.43MM | $-10.10MM | $-24.31MM |
| Non-Operating Income | $-1.35MM | $1.59MM | $-0.01MM |
| Interest Expense | $1.45MM | $0.00MM | $0.18MM |
| R&D Expense | $0.30MM | $4.85MM | $18.95MM |
| Income(Loss) | $-3.78MM | $-8.52MM | $-24.32MM |
| Taxes | $0.00MM | $0.01MM | $0.02MM |
| Profit(Loss) | $-3.78MM | $-8.52MM | $-24.34MM |
| Stockholders Equity | $5.47MM | $28.69MM | $12.32MM |
| Assets | $8.76MM | $31.40MM | $18.92MM |
| Operating Cash Flow | $-3.73MM | $-10.67MM | $-18.96MM |
| Financing Cash Flow | $12.83MM | $31.60MM | $7.79MM |
| Earnings Per Share* | $-1.24 | $-0.58 | $-1.25 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.